NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
- 13.07.2022
- Review
- Verfasst von
- Jin Wang
- Simeng Chen
- Min Liu
- Min Zhang
- Xiaoyi Jia
- Erschienen in
- Inflammopharmacology | Ausgabe 4/2022
Abstract
NIMA-related kinase 7 (NEK7) is a serine/threonine kinase, which is the smallest one in mammalian NEK family. At present, many studies have reported that NEK7 has a physiological role in regulating the cell cycle and promoting the mitotic process of cells. In recent years, an increasing number of studies have proposed that NEK7 is involved in the activation of the NLRP3 inflammasome. Under normal conditions, NEK7 is in a low activity state, while under pathological conditions, NEK7 is abnormally expressed and therefore plays a key role in the progression of multiple tumors and chronic inflammatory diseases. This review will concentrate on the mechanism of NEK7 participates in the process of mitosis and regulates the activation of NLRP3 inflammasome, the aberrant expression of NEK7 in a variety of tumors and chronic inflammatory diseases, and some potential inhibitors, which may provide some new ideas for the treatment of diverse tumors and chronic inflammatory diseases associated with NEK7.
Anzeige
- Titel
- NEK7: a new target for the treatment of multiple tumors and chronic inflammatory diseases
- Verfasst von
-
Jin Wang
Simeng Chen
Min Liu
Min Zhang
Xiaoyi Jia
- Publikationsdatum
- 13.07.2022
- Verlag
- Springer International Publishing
- Erschienen in
-
Inflammopharmacology / Ausgabe 4/2022
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608 - DOI
- https://doi.org/10.1007/s10787-022-01026-7
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.